No definition available.
Streptococcus and staphylococcus as the cause of diseases classified to other chapters
AB1_STREPTSTAPHYCOCC_INOTHER
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
206 |
4. Check minimum number of eventsNone |
206 |
5. Include endpointsNone |
206 |
6. Filter based on genotype QC (FinnGen only) |
206 |
Control definitions (FinnGen only)
- Control exclude
- AB1_BACT_BIR_OTHER_INF_AGENTS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Streptococcus and staphylococcus as the cause of diseases classified to other chapters
based on the number of shared cases.
Similar with more cases:
- Bacterial, viral and other infectious agents
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2560 | 1085 | 1457 |
| Only index persons | 1924 | 822 | 1102 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.03 | 0.04 |
| Only index persons | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 38.73 | 37.89 | 39.06 |
| Only index persons | 40.34 | 40.80 | 39.99 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 206 | 81 | 125 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.06 |
| Median age at first event (years) | 55.33 | 54.10 | 56.13 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 195
- Matched controls
- 1952
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B95.6
ICD-10 Finland
Staphylococcus aureus as the cause of diseases classified to other chapters
+∞
81.0
72
*
B95.0
ICD-10 Finland
Streptococcus, group A, as the cause of diseases classified to other chapters
+∞
30.0
28
*
J01FF01
ATC
clindamycin; systemic
4.8
22.2
97
331
B95.7
ICD-10 Finland
Other staphylococcus as the cause of diseases classified to other chapters
+∞
21.2
20
*
B95.4
ICD-10 Finland
Other streptococcus as the cause of diseases classified to other chapters
+∞
21.2
20
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.0
18.6
56
122
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
104.7
17.9
19
*
A41.9
ICD-10 Finland
Sepsis, unspecified
13.4
16.7
29
25
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
17.7
16.2
25
16
J04AB02
ATC
rifampicin; systemic
23.3
15.0
21
10
B95.3
ICD-10 Finland
Streptococcus pneumoniae as the cause of diseases classified to other chapters
161.6
14.7
15
*
C03CA01
ATC
furosemide; systemic
3.4
13.5
85
360
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
12.7
34
62
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.9
11.8
54
175
J01MA12
ATC
levofloxacin; systemic
3.7
11.7
60
211
B95.5
ICD-10 Finland
Unspecified streptococcus as the cause of diseases classified to other chapters
+∞
11.6
11
*
XF400
NOMESCO Finland
ECG with 12 standard connections
3.6
10.6
53
183
J01CF02
ATC
cloxacillin; systemic
10.5
10.5
20
21
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.2
10.2
40
112
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
7.5
10.0
23
34
R50.9
ICD-10 Finland
Fever, unspecified
3.6
9.9
48
161
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.8
9.8
33
79
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
9.9
9.8
19
21
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.6
9.8
48
163
A46
ICD-10 Finland
Erysipelas
3.6
9.8
48
163
M46.4
ICD-10 Finland
Discitis, unspecified
58.0
9.7
11
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
4.9
9.7
32
75
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.8
9.3
18
20
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
10.8
9.2
17
17
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
6.2
9.1
24
43
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.1
8.9
56
226
TK800
NOMESCO Finland
Hemodialysis
9.7
8.7
17
19
N18.8
ICD-10 Finland
Other chronic renal failure
8.5
8.6
18
23
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
13.6
8.5
14
11
201
Kela drug reimbursment
Chronic cardiac insufficiency
5.9
8.5
23
43
J01MA14
ATC
moxifloxacin; systemic
4.4
8.5
31
81
127
Kela drug reimbursment
Transplant complication
10.1
8.5
16
17
B95.1
ICD-10 Finland
Streptococcus, group B, as the cause of diseases classified to other chapters
+∞
8.4
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
8.2
71
345
WW200
NOMESCO Finland
Immunization
7.8
8.2
18
25
A40.8
ICD-10 Finland
Other streptococcal sepsis
34.9
8.2
10
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.3
8.1
30
79
V03AE01
ATC
polystyrene sulfonate; oral
23.2
8.1
11
5
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.4
8.1
17
22
J01CF05
ATC
flucloxacillin; systemic
6.2
7.8
20
35
TQW11
NOMESCO Finland
Vacuum treatment of wound
12.6
7.7
13
11
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
26.2
7.6
10
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.5
7.6
19
32
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
7.3
7.5
17
25
I33.9
ICD-10 Finland
Acute endocarditis, unspecified
+∞
7.3
7
*
J01MA02
ATC
ciprofloxacin; systemic
2.3
7.3
88
506
L30.4
ICD-10 Finland
Erythema intertrigo
31.3
7.2
9
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
21.0
7.2
10
5
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
12.7
7.2
12
10
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
7.2
55
249
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.6
7.1
13
13
L04AA01
ATC
[U] ciclosporin; systemic
10.6
7.1
13
13
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.3
7.1
37
130
R4110
NOMESCO Finland
Physiotherapy
2.5
7.0
67
342
A10AA02
ATC
NA
6.1
7.0
18
32
NHQ40
NOMESCO Finland
Amputation of toe
9.9
6.9
13
14
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
17.5
6.8
10
6
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
6.8
34
117
A11CC03
ATC
alfacalcidol; systemic
7.3
6.7
15
22
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
6.1
6.6
17
30
B01AB05
ATC
enoxaparin; parenteral
2.4
6.5
69
367
A12AA04
ATC
calcium carbonate; oral
8.6
6.4
13
16
A10AE04
ATC
insulin glargine; parenteral
3.5
6.3
29
93
V03AE02
ATC
sevelamer; oral
18.8
6.3
9
5
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
6.3
61
311
B95.2
ICD-10 Finland
Streptococcus group D and enterococcus as the cause of diseases classified to other chapters
+∞
6.3
6
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
6.3
40
162
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.1
6.2
14
21
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.1
6.1
23
62
Z94.0
ICD-10 Finland
Kidney transplant status
10.5
6.1
11
11
M04AA01
ATC
allopurinol; systemic
3.0
6.1
35
132
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042936) Bacteria identified in Isolate by Culture
75
227
4.62
23.32
3.3
2.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
36
69
6.11
18.73
2.1
2.1
g/l
1.7
1.6
0.29
30
56
(3007853) Bacteria identified in Skin by Aerobe culture
58
191
3.83
15.42
3.1
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
39
6.20
12.23
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
51
5.19
11.02
4.3
2.9
u/ml
0.2
0.3
1.76
17
31
(3023368) Bacteria identified in Blood by Culture
87
443
2.67
10.43
12.0
4.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
58
248
2.86
9.66
4.1
2.4
%
20.6
24.3
0.90
52
218
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
28
6.11
8.95
1.9
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
60
277
2.65
8.51
2.7
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
96
557
2.35
8.26
14.6
5.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
45
185
2.83
7.94
5.2
3.2
%
2.3
1.7
2.80
39
171
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
71
367
2.43
7.87
3.0
2.1
mg/l
3.0
3.0
0.01
62
325
(3021447) Carbon dioxide [Partial pressure] in Venous blood
41
166
2.84
7.42
11.8
4.1
kpa
5.6
5.7
0.22
41
161
(3000991) Gas panel - Venous blood
39
154
2.89
7.38
12.0
9.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
19
6.64
7.33
1.2
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
108
683
2.22
7.31
12.5
5.0
g/l
33.5
35.8
2.71
103
639
(40758558) Short blood count panel - Blood
76
421
2.28
7.07
26.1
7.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
39
158
2.81
7.03
4.6
3.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
105
664
2.19
7.03
4.8
2.6
ug/l
148.2
128.9
0.38
96
613
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
40
4.54
6.89
1.4
1.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
31
112
3.08
6.84
3.5
1.5
—
—
—
0
0
(3012544) pH of Venous blood
40
167
2.73
6.81
12.1
4.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
125
868
2.12
6.33
15.4
6.1
e9/l
1.7
1.9
2.31
118
762
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
26
93
3.06
5.82
10.7
4.4
mmol/l
23.3
23.9
0.49
26
86
(3024928) Oxygen saturation in Venous blood
13
28
4.89
5.82
7.9
3.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
80
482
2.08
5.81
5.7
2.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
99
647
2.02
5.74
17.3
8.2
inr
1.5
1.2
1.33
26
199
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
53
274
2.26
5.66
2.8
1.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
120
847
2.00
5.52
15.6
6.0
e9/l
0.6
0.6
0.84
112
730
(3006315) Basophils [#/volume] in Blood
120
850
1.99
5.43
15.7
6.0
e9/l
0.0
0.0
0.85
113
735
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
19
59
3.45
5.32
6.0
2.7
%
96.6
89.5
0.62
19
59
(3000494) Fungus identified in Specimen by Culture
41
196
2.36
5.22
1.7
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
19
5.48
5.09
1.8
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
121
873
1.94
5.04
17.4
6.3
e9/l
0.2
0.2
0.21
114
769
(40760888) Immunoglobulin light chains.free panel - Serum
15
41
3.87
5.02
2.7
4.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
41
201
2.30
4.92
2.9
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
44
223
2.24
4.88
2.1
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
49
260
2.16
4.86
4.5
2.0
s
31.8
29.5
1.68
49
255
(44790047)
12
29
4.33
4.69
2.2
1.4
—
—
—
0
0
(44790049)
12
29
4.33
4.69
2.2
1.4
—
—
—
0
0
(44806118)
12
29
4.33
4.69
2.2
1.4
—
—
—
0
0
(44790048)
12
29
4.33
4.69
2.2
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
41
206
2.24
4.63
2.9
1.9
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
11
8.49
4.61
1.4
1.3
iu/ml
163.8
193.4
—
9
11
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
21
4.95
4.58
1.3
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
65
3.12
4.58
3.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
39
3.78
4.57
1.9
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
39
3.78
4.57
1.9
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
35
3.90
4.44
2.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
50
3.39
4.44
2.2
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
45
3.52
4.42
2.0
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
72
454
1.90
4.38
5.0
2.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
40
204
2.19
4.35
37.6
24.3
inr
1.8
1.3
—
7
26
(3030467) Casts [#/volume] in Urine by Automated count
74
473
1.88
4.31
5.4
2.9
e6/l
0.7
0.4
0.37
61
355
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
23
4.52
4.13
2.6
2.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
23
93
2.66
4.13
2.0
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
66
413
1.88
4.07
11.1
4.3
%
84.7
88.2
0.45
66
408
(3021879) Hepatitis B virus core Ab [Presence] in Serum
28
126
2.41
4.05
2.0
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
34
167
2.24
4.04
3.4
2.4
u/l
29.4
33.8
0.27
29
141
(3019309) Folate [Moles/volume] in Red Blood Cells
50
288
1.97
3.93
1.9
1.7
nmol/l
1163.3
1231.1
0.17
39
222
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
55
3.07
3.83
1.9
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
12
34
3.69
3.83
2.3
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
68
438
1.82
3.79
4.0
3.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
98
704
1.75
3.77
13.2
7.3
mmol/l
1.2
1.2
1.42
86
640
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
52
313
1.88
3.57
7.1
3.9
ng/l
342.8
280.7
0.11
41
249
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
36
3.48
3.53
2.4
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
105
779
1.71
3.52
17.7
7.8
mmol/l
1.2
1.2
0.47
91
664
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
58
2.91
3.51
2.4
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
57
357
1.82
3.44
4.9
2.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
15
53
2.97
3.44
4.9
2.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
32
3.58
3.38
1.4
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
83
585
1.70
3.32
5.9
3.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
36
197
2.00
3.24
5.5
10.6
mmol/l
-2.0
1.1
2.30
27
163
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
46
274
1.87
3.24
3.8
2.9
e6/l
1.4
1.9
0.33
29
153
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
28
3.70
3.24
1.2
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
125
986
1.68
3.23
24.8
9.8
e9/l
3.9
4.1
0.58
120
860
(3021960) Folate [Moles/volume] in Serum or Plasma
58
373
1.77
3.19
1.6
1.5
nmol/l
19.5
20.5
0.20
50
311
(3002582) Erythrocytes [#/volume] in Urine
75
519
1.70
3.18
6.4
3.2
e6/l
908.7
173.4
0.41
63
403
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
50
2.93
3.15
2.2
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
20
4.65
3.15
2.2
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
21
415
0.45
3.11
2.9
2.9
ug/l
2.0
0.7
0.40
14
270
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
34
3.36
3.10
1.2
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
12
5.99
3.04
1.7
2.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
12
5.99
3.04
3.6
6.0
%
73.9
92.3
—
7
12
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
12
5.99
3.04
1.7
2.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
12
5.99
3.04
1.7
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
69
473
1.69
3.00
12.4
4.2
ph
7.4
7.4
0.19
12
77
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
85
617
1.64
2.97
2.2
1.9
pmol/l
79.6
96.0
3.24
51
318
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
52
2.82
2.95
1.4
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
53
339
1.76
2.95
5.0
2.8
mosm/kgh2o
542.1
584.6
0.93
48
283
(3021788) Differential panel - Synovial fluid
9
22
4.23
2.92
1.7
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
22
4.23
2.92
4.1
3.9
%
55.1
60.7
—
9
22
(3018095) Leukocytes [#/volume] in Urine
82
594
1.63
2.86
7.3
3.8
e6/l
85.5
41.6
0.70
65
426
(3019230) Fractional oxyhemoglobin in Venous blood
9
23
4.04
2.81
7.3
2.2
%
65.9
59.2
—
9
23
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
92
2.30
2.77
6.9
14.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
94
710
1.60
2.74
6.7
4.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
10
6.14
2.71
5.2
2.7
u/ml
946.2
732.0
—
6
10
(3021589) Normoblasts [#/volume] in Blood
97
744
1.57
2.61
22.9
9.6
e9/l
0.0
0.0
0.42
83
599
(3004588) Protein electrophoresis panel - Serum or Plasma
22
109
2.14
2.57
2.7
1.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
125
1022
1.57
2.51
6.3
4.4
—
337.1
—
0
22
(3051611) Lipemic interference index of Serum or Plasma
7
16
4.49
2.49
4.4
3.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
21
3.92
2.49
4.4
3.1
e9/l
5.6
4.4
—
8
21
(3017143) Hepatitis C virus Ab [Presence] in Serum
34
200
1.84
2.48
2.5
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
125
2.04
2.48
3.0
3.3
ml/min/173m2
62.4
67.4
0.19
11
56
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
34
3.04
2.45
1.7
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
12
5.11
2.42
1.3
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
5
8
6.37
2.38
1.6
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
17
4.22
2.38
2.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
35
2.95
2.34
2.2
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
45
293
1.69
2.33
3.8
2.7
e6/l
1.4
1.0
0.38
28
170
(3051651) Icteric interference index of Serum or Plasma
6
13
4.72
2.29
4.8
3.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
18
3.99
2.27
1.3
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
18
3.99
2.27
1.4
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
144
1619
0.63
2.26
5.1
4.9
mmol/l
2.5
2.7
1.62
129
1487
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
50
339
1.63
2.21
3.3
1.8
mg/l
2.1
1.2
0.43
42
261
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
24
3.42
2.20
2.9
2.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
30
3.09
2.17
1.1
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
51
350
1.61
2.15
1.9
1.5
g/l
2.8
2.6
0.28
35
213
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
37
553
0.60
2.14
3.6
4.3
%
22.4
20.6
0.28
12
253
(3011288) Drugs identified in Urine by Screen method
10
37
2.79
2.13
1.9
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
43
2.65
2.13
1.1
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
25
3.29
2.12
1.6
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
9
31
2.99
2.10
2.0
2.0
—
11313.6
—
0
8
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
10
5.09
2.08
1.0
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
83
640
1.50
2.07
3.5
2.4
nmol/l
73.9
77.1
0.39
75
564
(3015377) Calcium [Moles/volume] in Serum or Plasma
68
503
1.53
2.06
6.7
3.1
mmol/l
2.3
2.4
0.58
60
434
(4062490)
6
15
4.09
2.05
1.3
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
25
142
1.87
2.04
7.5
4.1
%
0.8
0.9
0.06
11
44
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
27
3.04
1.95
2.9
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
141
1579
0.66
1.95
4.6
4.4
mmol/l
1.3
1.4
1.55
124
1445
(3021440) Promyelocytes/100 leukocytes in Blood
23
129
1.88
1.95
7.2
4.2
%
0.1
0.2
—
9
38
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
39
2.64
1.95
1.6
1.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
12
52
2.39
1.91
12.5
3.6
kpa
8.6
8.9
0.22
12
46
(3041354) Potassium [Moles/volume] in Venous blood
7
22
3.26
1.89
3.3
2.5
mmol/l
4.0
4.0
—
7
22
(3035285) Chloride [Moles/volume] in Venous blood
7
22
3.26
1.89
3.3
2.5
mmol/l
107.1
106.7
—
7
22
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
22
3.26
1.89
3.3
2.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
12
4.24
1.83
2.2
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
36
2.57
1.76
2.0
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
18
3.40
1.76
3.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
18
3.40
1.76
1.0
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
7
24
2.98
1.74
2.6
2.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
139
1542
0.70
1.58
4.7
4.5
mmol/l
6.2
6.0
0.95
124
1408
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
57
2.17
1.58
2.7
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
137
1523
0.70
1.57
4.4
4.0
mmol/l
1.4
1.3
0.66
121
1394
(3019225) pH of Specimen
22
131
1.76
1.57
8.4
4.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
142
1254
1.43
1.55
20.4
8.0
u/l
96.9
81.0
2.52
135
1174
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
144
1585
0.70
1.53
4.8
4.5
mmol/l
4.4
4.6
1.54
130
1465
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
15
3.39
1.53
1.8
2.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
27
2.65
1.53
1.1
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
27
2.65
1.53
1.6
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
27
2.65
1.53
9.9
2.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
21
2.91
1.51
2.2
1.6
—
—
—
0
0
(4306422)
7
28
2.55
1.46
1.0
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
28
2.55
1.46
1.3
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
16
3.18
1.44
1.4
3.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
22
2.78
1.44
2.2
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
22
2.78
1.44
2.2
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
22
2.78
1.44
4.2
3.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
81
1.92
1.44
4.7
4.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
164
0.47
1.43
1.3
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
53
2.14
1.41
2.4
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
18
105
1.78
1.38
9.9
3.9
mmol/l
1.3
2.4
0.26
11
74
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
23
2.66
1.37
2.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
23
2.66
1.37
2.0
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
23
2.66
1.37
2.0
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
68
1.97
1.36
1.0
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
98
1.80
1.36
1.2
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
54
2.10
1.35
2.8
2.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
34
2.41
1.30
5.8
2.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
12
62
1.99
1.30
3.3
12.7
%
2.5
1.6
0.92
12
57
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
18
2.82
1.29
1.2
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
77
1.88
1.29
2.7
2.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
77
1.88
1.29
1.7
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
56
434
1.40
1.29
6.2
2.9
umol/l
15504.4
7422.2
0.22
51
372
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
25
2.44
1.25
1.7
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
45
2.04
1.25
1.6
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
49
2.09
1.24
1.5
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
49
2.09
1.24
1.5
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
19
118
1.67
1.20
3.2
8.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
26
2.35
1.19
1.0
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
18
112
1.67
1.13
10.2
7.7
mmol/l
22.9
24.7
0.75
18
112
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
135
1477
0.75
1.13
8.1
5.9
mmol/mol
42.5
40.4
1.12
121
1375
(1761868) Lipid panel - Serum or Plasma
47
596
0.73
1.12
3.1
2.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
31
221
1.47
1.11
1.1
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
16
98
1.69
1.07
5.4
2.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
46
2.00
1.05
1.0
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
22
2.30
1.04
2.4
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
22
2.30
1.04
2.4
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
9
47
1.96
1.03
3.9
16.1
mmol/l
1.2
1.2
—
9
42
(1761482) Bacteria [#/volume] in Urine by Culture
9
47
1.96
1.03
4.0
6.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
47
1.96
1.03
1.6
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
49
387
1.35
1.00
3.2
3.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
23
2.20
0.98
2.4
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
145
0.53
0.97
1.9
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
19
126
1.56
0.95
1.2
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
28
2.18
0.92
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
34
440
0.73
0.91
6.6
3.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
79
1.69
0.90
1.5
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
29
2.10
0.90
1.5
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
8
43
1.89
0.88
1.1
1.4
—
60.0
—
0
7
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
30
2.03
0.87
1.0
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
6
30
2.03
0.87
1.2
1.3
—
1.7
—
0
9
(3022313) Gas panel - Capillary blood
14
88
1.63
0.87
9.1
4.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
57
680
0.78
0.86
4.1
4.9
ug/l
3.0
2.5
0.11
50
606
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
31
1.96
0.85
2.0
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
47
381
1.30
0.81
10.3
5.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
33
1.84
0.79
1.7
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
59
1.73
0.77
2.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
34
1.79
0.77
2.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
34
1.79
0.77
1.8
2.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
54
451
1.27
0.74
5.5
3.3
mg/l
1295.0
331.3
0.38
39
303
(3049717) Cytology report of Urine Cyto stain
9
56
1.63
0.73
1.7
2.7
—
—
—
0
0
(4268621)
5
25
2.02
0.73
1.8
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
57
480
1.26
0.73
6.9
4.1
mg/mmol
23.1
7.8
1.06
41
317
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
22
161
1.41
0.72
1.5
1.4
—
—
—
0
0
(3013512) EKG study
52
434
1.27
0.72
4.0
4.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
61
1.67
0.70
2.0
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
166
1736
0.77
0.69
24.2
10.6
u/l
29.4
27.1
0.89
160
1672
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
27
1.87
0.69
1.6
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
43
1.65
0.67
1.7
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
43
1.65
0.67
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
164
1716
0.78
0.67
26.2
13.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
57
485
1.24
0.67
5.6
3.2
mmol/l
6.9
8.0
1.06
46
408
(40768793) Breast Pathology biopsy report
5
28
1.80
0.66
1.0
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
28
1.80
0.66
7.8
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
17
121
1.44
0.64
2.8
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
29
1.74
0.64
1.2
1.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
5
29
1.74
0.64
5.4
2.6
kpa
4.8
4.9
—
5
29
(3027315) Oxygen [Partial pressure] in Blood
5
29
1.74
0.64
5.4
2.6
kpa
7.9
8.7
—
5
29
(3027008) Opiates [Presence] in Urine
10
63
1.62
0.63
2.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
63
1.62
0.63
2.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
63
1.62
0.63
2.0
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
53
616
0.81
0.62
5.4
3.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
51
1.59
0.61
1.0
1.3
—
3.6
—
0
6
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
23
0.00
0.58
0.0
3.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
60
1.52
0.55
1.6
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
40
335
1.24
0.54
1.9
1.8
pmol/l
369.9
442.9
1.38
35
290
(3002256) Pathology report gross observation
25
197
1.31
0.54
1.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
39
1.55
0.53
1.7
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
119
1106
1.18
0.53
6.9
4.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
40
1.51
0.52
6.2
2.0
nmol/l
0.5
0.7
—
6
33
(3019150) Specific gravity of Urine by Refractometry
29
353
0.79
0.51
3.9
4.3
kg/l
1.0
1.0
—
7
47
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
144
1513
0.84
0.51
33.8
13.5
ml/min/173m2
79.6
82.0
0.49
127
1220
(3009542) Hematocrit [Volume Fraction] of Blood
158
1508
1.20
0.50
41.3
15.2
%
36.0
40.5
4.48
116
1121
(3000492) Spirometry study
21
165
1.30
0.47
1.7
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
165
1.30
0.47
3.1
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
49
426
1.20
0.47
1.8
1.7
mmol/l
1.6
1.3
0.70
40
361
(3037522) Nuclear Ab [Titer] in Serum
28
229
1.26
0.47
1.5
1.4
titre
460.0
374.2
—
8
48
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
184
0.74
0.44
16.3
8.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
129
1218
1.16
0.43
7.4
4.2
mm/h
16.3
11.3
2.56
118
1111
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
31
1.63
0.43
1.0
1.5
—
—
—
0
0
(4146454)
0
16
0.00
0.41
0.0
3.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.7
—
15.9
—
0
17
(40761536) Microorganisms panel - Urine sediment
16
124
1.31
0.40
6.2
3.5
—
—
—
0
0
(3019977) pH of Arterial blood
0
19
0.00
0.39
0.0
6.3
—
7.4
—
0
5
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
19
0.00
0.39
0.0
3.9
—
38.3
—
0
7
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
41
359
1.18
0.37
1.5
1.4
u/ml
0.7
0.8
—
7
89
(1002224) Polysomnography panel
5
76
0.65
0.36
1.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
43
1.41
0.35
1.0
1.1
—
4.8
—
0
5
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
166
1614
1.15
0.29
41.1
14.7
mg/l
27.7
23.2
1.18
151
1267
(3008898) HLA-B27 [Presence]
5
74
0.67
0.26
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
122
1172
1.10
0.25
4.0
3.8
pmol/l
14.5
14.8
0.43
112
1060
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
77
1.18
0.24
1.1
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
85
806
1.09
0.22
6.8
5.1
estimate
0.0
0.0
0.00
12
150
(4094501)
5
42
1.20
0.21
1.4
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
5
42
1.20
0.21
1.4
1.5
—
337.8
—
0
20
(1617658) Protocol used for examination of sentinel lymph nodes
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
1.0
—
0
10
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(44813793)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.6
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
9.9
—
813.0
—
0
13
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
17.6
—
1308.8
—
0
13
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
13
0.00
0.21
0.0
2.5
—
13.3
—
0
13
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
4.2
—
86.0
—
0
14
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
185
1.15
0.19
3.4
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
58
1.21
0.18
1.3
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
64
605
1.08
0.18
2.1
2.0
—
—
—
0
0
(3020891) Body temperature
7
62
1.13
0.17
5.0
5.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
30
273
1.12
0.17
1.2
1.3
u/ml
4.0
6.3
0.33
15
106
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
67
0.74
0.17
2.2
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
85
814
1.08
0.17
5.1
3.8
estimate
0.0
0.0
0.00
15
139
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
101
1.20
0.17
1.2
1.4
iu/ml
92.5
121.7
—
5
35
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
13
111
1.18
0.16
1.3
1.2
—
25.4
—
0
7
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
33
304
1.10
0.15
1.8
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
169
1.14
0.15
1.9
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
40
428
0.92
0.15
4.5
4.1
estimate
0.0
0.0
0.50
13
138
(3022145) Colonoscopy Study observation
20
179
1.13
0.15
1.3
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
108
1049
1.06
0.13
3.4
3.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
108
1109
0.95
0.12
4.4
3.4
u/l
83.9
48.9
1.42
98
1039
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
142
1445
0.94
0.11
4.9
4.5
mu/l
1.9
1.9
0.15
130
1310
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
45
1.11
0.10
1.4
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
14
126
1.12
0.09
2.3
2.3
—
7.9
—
0
5
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
80
0.87
0.07
5.7
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
82
803
1.04
0.06
4.6
3.7
estimate
0.0
0.0
0.00
12
147
(3044889) 12 lead EKG panel
114
1130
1.02
0.02
5.3
3.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
42
411
1.03
0.02
1.7
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
28
286
0.98
0.00
1.3
1.3
iu/ml
18.7
34.4
—
9
94
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
149
1.01
0.00
1.3
1.7
—
—
—
0
0
(4010399)
12
117
1.03
0.00
1.4
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
64
637
1.01
0.00
3.6
3.9
ng/l
33.2
42.5
0.34
45
443
(4035726)
14
142
0.98
0.00
1.7
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
13
132
0.98
0.00
2.7
3.8
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
8
0.00
0.00
0.0
2.1
—
3.2
—
0
8
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
8
0.00
0.00
0.0
2.5
—
20.6
—
0
8
(3015183) Erythrocyte sedimentation rate
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
55
0.91
0.00
1.6
1.7
pmol/l
129.6
267.1
—
5
49
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
24.5
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
82
0.97
0.00
1.5
1.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
6
0.00
0.00
0.0
5.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.0
—
9.1
—
0
7
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
6.8
1.8
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
38.2
—
0
5
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.8
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
94.4
—
0
6
(3018133) Calcium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
3.4
—
4.3
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_STREPTSTAPHYCOCC_INOTHER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_STREPTSTAPHYCOCC_INOTHER | 2.548 [1.94, 3.35] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.489 |
During the follow-up period (1.1.1998 — 31.12.2019), 185 out of 872 females with AB1_STREPTSTAPHYCOCC_INOTHER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_STREPTSTAPHYCOCC_INOTHER | 3.059 [2.4, 3.9] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 310 out of 1147 males with AB1_STREPTSTAPHYCOCC_INOTHER died.
Mortality risk
Mortality risk for people of age
years, who have AB1_STREPTSTAPHYCOCC_INOTHER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.3% | 0.628% |
| 5 | 1.742% | 3.201% |
| 10 | 4.149% | 8.239% |
| 15 | 7.55% | 15.117% |
| 20 | 13.582% | 24.671% |
Relationships between endpoints
↥Index endpoint: AB1_STREPTSTAPHYCOCC_INOTHER – Streptococcus and staphylococcus as the cause of diseases classified to other chapters
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data